Acquired thrombotic thrombocytopenic purpura in children: A single institution experience

Somasundaram Jayabose, Theodore S. Nowicki, Julie Dunbar, Oya Levendoglu-Tugal, Mehmet F. Ozkaynak, Claudio Sandoval

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single institution experience. Methods: This study is a retrospective review of all 12 children with TTP seen at New York Medical College- Westchester Medical Center during a period of 15 y from 1993 to 2008. Results: There were 7 females and 5 males with acquired TTP, with a median age of 13 (range, 6-17); and no cases of congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was seen in only three patients. Nine had renal involvement; eight had neurologic symptoms; and four had fever. All 12 patients had thrombocytopenia, anemia, and elevated LDH. Nine had idiopathic TTP. Three patients had one of the following underlying disorders: systemic lupus erythematosus, mixed connective tissue disorder, and aplastic anemia (post-bone marrow transplant on cyclosporine). ADAMTS13 level was decreased in 7 of 8 patients studied. Eight of 10 patients achieved remission with plasmapheresis alone. Two needed additional treatment before achieving remission. Two had one or more relapses, requiring immunosupressive treatment with vincrisine, prednisone, or rituximab. The patient with aplastic anemia died of pulmonary hypertension 5 y after bone marrow transplantation. All other 11 patients are alive and free of TTP for a median follow-up of 12 mo (range, 3-72 mo). Conclusions: Acquired pediatric TTP responds well to plasmapheresis. However, many patients do require additional treatment because of refractoriness to plasmapheresis or relapse. The clinical features, response to treatment, and relapse rate of pediatric TTP appear similar to those of adult TTP.

Original languageEnglish (US)
Pages (from-to)570-575
Number of pages6
JournalIndian Journal of Pediatrics
Volume80
Issue number7
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Thrombotic Thrombocytopenic Purpura
Plasmapheresis
Aplastic Anemia
Neurologic Manifestations
Recurrence
Thrombocytopenia
Fever
Pediatrics
Kidney
Therapeutics
Acquired Thrombotic thrombocytopenic purpura
Hemolytic Anemia
Prednisone
Bone Marrow Transplantation
Pulmonary Hypertension
Systemic Lupus Erythematosus
Connective Tissue
Cyclosporine
Anemia
Bone Marrow

Keywords

  • ADAMTS13
  • Cyclosporine
  • Pediatric TTP
  • Plasmapheresis
  • Rituximab
  • Thrombotic thrombocytopenic purpura (TTP)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Acquired thrombotic thrombocytopenic purpura in children : A single institution experience. / Jayabose, Somasundaram; Nowicki, Theodore S.; Dunbar, Julie; Levendoglu-Tugal, Oya; Ozkaynak, Mehmet F.; Sandoval, Claudio.

In: Indian Journal of Pediatrics, Vol. 80, No. 7, 07.2013, p. 570-575.

Research output: Contribution to journalArticle

Jayabose, S, Nowicki, TS, Dunbar, J, Levendoglu-Tugal, O, Ozkaynak, MF & Sandoval, C 2013, 'Acquired thrombotic thrombocytopenic purpura in children: A single institution experience', Indian Journal of Pediatrics, vol. 80, no. 7, pp. 570-575. https://doi.org/10.1007/s12098-012-0940-4
Jayabose, Somasundaram ; Nowicki, Theodore S. ; Dunbar, Julie ; Levendoglu-Tugal, Oya ; Ozkaynak, Mehmet F. ; Sandoval, Claudio. / Acquired thrombotic thrombocytopenic purpura in children : A single institution experience. In: Indian Journal of Pediatrics. 2013 ; Vol. 80, No. 7. pp. 570-575.
@article{8ab5f81343ff44698ec7b9bc43f1ef08,
title = "Acquired thrombotic thrombocytopenic purpura in children: A single institution experience",
abstract = "Objective: To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single institution experience. Methods: This study is a retrospective review of all 12 children with TTP seen at New York Medical College- Westchester Medical Center during a period of 15 y from 1993 to 2008. Results: There were 7 females and 5 males with acquired TTP, with a median age of 13 (range, 6-17); and no cases of congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was seen in only three patients. Nine had renal involvement; eight had neurologic symptoms; and four had fever. All 12 patients had thrombocytopenia, anemia, and elevated LDH. Nine had idiopathic TTP. Three patients had one of the following underlying disorders: systemic lupus erythematosus, mixed connective tissue disorder, and aplastic anemia (post-bone marrow transplant on cyclosporine). ADAMTS13 level was decreased in 7 of 8 patients studied. Eight of 10 patients achieved remission with plasmapheresis alone. Two needed additional treatment before achieving remission. Two had one or more relapses, requiring immunosupressive treatment with vincrisine, prednisone, or rituximab. The patient with aplastic anemia died of pulmonary hypertension 5 y after bone marrow transplantation. All other 11 patients are alive and free of TTP for a median follow-up of 12 mo (range, 3-72 mo). Conclusions: Acquired pediatric TTP responds well to plasmapheresis. However, many patients do require additional treatment because of refractoriness to plasmapheresis or relapse. The clinical features, response to treatment, and relapse rate of pediatric TTP appear similar to those of adult TTP.",
keywords = "ADAMTS13, Cyclosporine, Pediatric TTP, Plasmapheresis, Rituximab, Thrombotic thrombocytopenic purpura (TTP)",
author = "Somasundaram Jayabose and Nowicki, {Theodore S.} and Julie Dunbar and Oya Levendoglu-Tugal and Ozkaynak, {Mehmet F.} and Claudio Sandoval",
year = "2013",
month = "7",
doi = "10.1007/s12098-012-0940-4",
language = "English (US)",
volume = "80",
pages = "570--575",
journal = "Indian Journal of Pediatrics",
issn = "0019-5456",
publisher = "Springer India",
number = "7",

}

TY - JOUR

T1 - Acquired thrombotic thrombocytopenic purpura in children

T2 - A single institution experience

AU - Jayabose, Somasundaram

AU - Nowicki, Theodore S.

AU - Dunbar, Julie

AU - Levendoglu-Tugal, Oya

AU - Ozkaynak, Mehmet F.

AU - Sandoval, Claudio

PY - 2013/7

Y1 - 2013/7

N2 - Objective: To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single institution experience. Methods: This study is a retrospective review of all 12 children with TTP seen at New York Medical College- Westchester Medical Center during a period of 15 y from 1993 to 2008. Results: There were 7 females and 5 males with acquired TTP, with a median age of 13 (range, 6-17); and no cases of congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was seen in only three patients. Nine had renal involvement; eight had neurologic symptoms; and four had fever. All 12 patients had thrombocytopenia, anemia, and elevated LDH. Nine had idiopathic TTP. Three patients had one of the following underlying disorders: systemic lupus erythematosus, mixed connective tissue disorder, and aplastic anemia (post-bone marrow transplant on cyclosporine). ADAMTS13 level was decreased in 7 of 8 patients studied. Eight of 10 patients achieved remission with plasmapheresis alone. Two needed additional treatment before achieving remission. Two had one or more relapses, requiring immunosupressive treatment with vincrisine, prednisone, or rituximab. The patient with aplastic anemia died of pulmonary hypertension 5 y after bone marrow transplantation. All other 11 patients are alive and free of TTP for a median follow-up of 12 mo (range, 3-72 mo). Conclusions: Acquired pediatric TTP responds well to plasmapheresis. However, many patients do require additional treatment because of refractoriness to plasmapheresis or relapse. The clinical features, response to treatment, and relapse rate of pediatric TTP appear similar to those of adult TTP.

AB - Objective: To describe the clinical features, treatment and prognosis of acquired thrombotic thrombocytopenic purpura (TTP) in children based on a single institution experience. Methods: This study is a retrospective review of all 12 children with TTP seen at New York Medical College- Westchester Medical Center during a period of 15 y from 1993 to 2008. Results: There were 7 females and 5 males with acquired TTP, with a median age of 13 (range, 6-17); and no cases of congenital TTP. The classic pentad of TTP (microangiopathic hemolytic anemia, thrombocytopenia, neurologic symptoms, renal dysfunction and fever) was seen in only three patients. Nine had renal involvement; eight had neurologic symptoms; and four had fever. All 12 patients had thrombocytopenia, anemia, and elevated LDH. Nine had idiopathic TTP. Three patients had one of the following underlying disorders: systemic lupus erythematosus, mixed connective tissue disorder, and aplastic anemia (post-bone marrow transplant on cyclosporine). ADAMTS13 level was decreased in 7 of 8 patients studied. Eight of 10 patients achieved remission with plasmapheresis alone. Two needed additional treatment before achieving remission. Two had one or more relapses, requiring immunosupressive treatment with vincrisine, prednisone, or rituximab. The patient with aplastic anemia died of pulmonary hypertension 5 y after bone marrow transplantation. All other 11 patients are alive and free of TTP for a median follow-up of 12 mo (range, 3-72 mo). Conclusions: Acquired pediatric TTP responds well to plasmapheresis. However, many patients do require additional treatment because of refractoriness to plasmapheresis or relapse. The clinical features, response to treatment, and relapse rate of pediatric TTP appear similar to those of adult TTP.

KW - ADAMTS13

KW - Cyclosporine

KW - Pediatric TTP

KW - Plasmapheresis

KW - Rituximab

KW - Thrombotic thrombocytopenic purpura (TTP)

UR - http://www.scopus.com/inward/record.url?scp=84887839621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887839621&partnerID=8YFLogxK

U2 - 10.1007/s12098-012-0940-4

DO - 10.1007/s12098-012-0940-4

M3 - Article

C2 - 23263974

AN - SCOPUS:84887839621

VL - 80

SP - 570

EP - 575

JO - Indian Journal of Pediatrics

JF - Indian Journal of Pediatrics

SN - 0019-5456

IS - 7

ER -